Dual-action nanoparticle therapy targets obesity by converting white fat and reducing inflammation at Salimpour Site.

Dr. Salimpour Site |Scientists at the Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary ...

Phys.Org

Dual-action nanoparticle therapy targets obesity by converting white fat and reducing inflammation

Dual-action nanoparticle therapy targets obesity by converting white fat and reducing inflammation

Scientists at the Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary ...